Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., June 19, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company…
3,420$
-1,30%
Echtzeit-Aktienkurs Neuronetics
Bid:
Ask:
Nachrichten zur Neuronetics Aktie
Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes
MALVERN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical…
Neuronetics, Inc. (STIM) Q1 2025 Earnings Call Transcript
…
Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results
MALVERN, Pa., March 27, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) is issuing…
Neuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call
MALVERN, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on…
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company…
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”) today announced the granting…
Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference
MALVERN, Pa., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on…
Neuronetics and Greenbrook TMS get interim order for merger
…
STIM Stock Likely to Gain From Updated TMS Coverage
Neuronetics announces that TMS coverage has been updated to reduce access barriers for patients with MDD. In line with this,…
Neuronetics (STIM) Latest Deal to Aid Mental Health Treatments
Neuronetics (STIM) announces the acquisition of Greenbrook to provide better care to patients suffering from mental health conditions.…
Neuronetics (STIM) Inks a New Merger Agreement With Greenbrook
Neuronetics (STIM) signs a merger agreement with Greenbrook to acquire all its outstanding shares. The transaction is expected to be…
Neuronetics (STIM) Q2 Loss Wider Than Expected, Revenues Fall Y/Y
Neuronetics (STIM) second-quarter 2024 top-line results reflect lower revenues from NeuroStar Advanced Therapy System and Treatment sessions.…
Neuronetics, Inc. (STIM) Q2 2024 Earnings Call Transcript
…
Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge
MALVERN, Pa. and TORONTO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (“Neuronetics”) and Greenbrook TMS…
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company…
Neuronetics (STIM) Expands NeuroStar Portfolio With New Launch
Neuronetics (STIM) announces the nationwide launch of the Better Me Provider (BMP) program developed in collaboration with TMS medical experts.…
Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference
MALVERN, Pa., May 23, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on…
Neuronetics, Inc. (STIM) Q1 2024 Earnings Call Transcript
…
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company…
Neuronetics (STIM) FDA-Cleared NeuroStar to Aid in Depression
Neuronetics (STIM) announces the FDAs approval of NeuroStar Advanced Therapy, which is likely to aid in the treatment of depression…
Neuronetics (STIM) Progresses in MRD and TRD With New Deal
The collaboration between Neuronetics (STIM) and TCN holds particular significance in the realm of treatment-resistant depression.…
Earnings call: Neuronetics shows growth and positive cash flow outlook By Investing.com
Earnings call: Neuronetics shows growth and positive cash flow outlook…
Neuronetics, Inc. (STIM) Q4 2023 Earnings Call Transcript
…
Neuronetics Q4 2023 Earnings Preview
…